<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.bbadva.2021.100028"><dct:format>application/xml</dct:format><dct:title>The balance of concentration between Prokineticin 2&#x03b2; and Prokineticin 2 modulates the food intake by STAT3 signaling</dct:title><dct:creator>Daniela Maftei</dct:creator><dct:creator>Roberta Lattanzi</dct:creator><dct:creator>Martina Vincenzi</dct:creator><dct:creator>Silvia Squillace</dct:creator><dct:creator>Maria Rosaria Fullone</dct:creator><dct:creator>Rossella Miele</dct:creator><dct:subject><rdf:Bag><rdf:li>Food intake regulation</rdf:li><rdf:li>Adipocytes</rdf:li><rdf:li>Prokineticin 2</rdf:li><rdf:li>Prokineticin 2&#x03b2;</rdf:li><rdf:li>Prokineticin receptor 1</rdf:li></rdf:Bag></dct:subject><dct:description>BBA Advances 1 (2021). doi:10.1016/j.bbadva.2021.100028</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>BBA Advances</prism:publicationName><prism:copyright>&#169; 2021 The Authors. Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-1603</prism:issn><prism:volume>1</prism:volume><prism:coverDisplayDate>2021</prism:coverDisplayDate><prism:doi>10.1016/j.bbadva.2021.100028</prism:doi><prism:url>http://dx.doi.org/10.1016/j.bbadva.2021.100028</prism:url><dct:identifier>doi:10.1016/j.bbadva.2021.100028</dct:identifier><bam:articleNumber>100028</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-10-05T13:58:54Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#ElsevierWaived</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>BBADVA</ja:jid><ja:aid>100028</ja:aid><ce:article-number>100028</ce:article-number><ce:pii>S2667-1603(21)00027-2</ce:pii><ce:doi>10.1016/j.bbadva.2021.100028</ce:doi><ce:copyright type="other" year="2021">The Authors</ce:copyright></ja:item-info><ja:head><ce:title id="tte0002">The balance of concentration between Prokineticin 2&#x03b2; and Prokineticin 2 modulates the food intake by STAT3 signaling</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667160321000272-9222a953d19ac71fadc804e0b2cc9178"><ce:given-name>Daniela</ce:given-name><ce:surname>Maftei</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0002" author-id="S2667160321000272-1e5e92503ad0c47598e7fbecb324866b"><ce:given-name>Roberta</ce:given-name><ce:surname>Lattanzi</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:roberta.lattanzi@uniroma1.it">roberta.lattanzi@uniroma1.it</ce:e-address></ce:author><ce:author id="au0003" author-id="S2667160321000272-e80614ec8762fb91bc2d9b5c18e03e5a"><ce:given-name>Martina</ce:given-name><ce:surname>Vincenzi</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2667160321000272-939693cc89d052f55da36e919a04e365"><ce:given-name>Silvia</ce:given-name><ce:surname>Squillace</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2667160321000272-e27c97b975bfe1ff8d79818ea3f865d2"><ce:given-name>Maria Rosaria</ce:given-name><ce:surname>Fullone</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S2667160321000272-b466bf497052e0a43b734df9ef3872c7"><ce:given-name>Rossella</ce:given-name><ce:surname>Miele</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667160321000272-62257e58dc3aafb31522c8a9cca40dcc"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Department of Physiology and Pharmacology &#x201c;Vittorio Erspamer&#x201d;, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy</ce:textfn><sa:affiliation><sa:organization>Department of Physiology and Pharmacology &#x201c;Vittorio Erspamer&#x201d;</sa:organization><sa:organization>Sapienza University of Rome</sa:organization><sa:address-line>Piazzale Aldo Moro 5</sa:address-line><sa:city>Rome</sa:city><sa:postal-code>I-00185</sa:postal-code><sa:country>Italy</sa:country></sa:affiliation><ce:source-text id="staff0001">aDepartment of Physiology and Pharmacology &#x201c;Vittorio Erspamer&#x201d;, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2667160321000272-8f96aba61aef5f0028fff58ef3f1410d"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Department of Biochemical Sciences &#x201c;A. Rossi Fanelli&#x201d; and CNR-Institute of Molecular Biology and Pathology, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy</ce:textfn><sa:affiliation><sa:organization>Department of Biochemical Sciences &#x201c;A. Rossi Fanelli&#x201d; and CNR-Institute of Molecular Biology and Pathology</sa:organization><sa:organization>Sapienza University of Rome</sa:organization><sa:address-line>Piazzale Aldo Moro 5</sa:address-line><sa:city>Rome</sa:city><sa:postal-code>I-00185</sa:postal-code><sa:country>Italy</sa:country></sa:affiliation><ce:source-text id="staff0002">bDepartment of Biochemical Sciences &#x201c;A. Rossi Fanelli&#x201d; and CNR-Institute of Molecular Biology and Pathology, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author: Roberta Lattanzi, Department of Physiology and Pharmacology &#x201c;Vittorio Erspamer&#x201d; Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.</ce:text><sa:affiliation><sa:organization>Department of Physiology and Pharmacology &#x201c;Vittorio Erspamer&#x201d;</sa:organization><sa:organization>Sapienza University of Rome</sa:organization><sa:address-line>Piazzale Aldo Moro 5</sa:address-line><sa:city>Rome</sa:city><sa:postal-code>I-00185</sa:postal-code><sa:country>Italy</sa:country></sa:affiliation></ce:correspondence></ce:author-group><ce:date-received day="3" month="5" year="2021"/><ce:date-revised day="1" month="10" year="2021"/><ce:date-accepted day="5" month="10" year="2021"/><ce:abstract id="abs0001" class="author-highlights" view="all"><ce:section-title id="cesectitle0001">Highlights</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara007" view="all"><ce:list id="celist0001"><ce:list-item id="celistitem0001"><ce:label>&#x2022;</ce:label><ce:para id="para0001" view="all">PK2&#x03b2; intraperitoneal administration does not reduce food intake.</ce:para></ce:list-item><ce:list-item id="celistitem0002"><ce:label>&#x2022;</ce:label><ce:para id="para0002" view="all">PK2, but not PK2&#x03b2;, activates STAT3 and ERK in hypothalamus explants.</ce:para></ce:list-item><ce:list-item id="celistitem0003"><ce:label>&#x2022;</ce:label><ce:para id="para0003" view="all">PKR1-KO mice adipocytes show impaired levels of STAT3 and ERK activation.</ce:para></ce:list-item><ce:list-item id="celistitem0004"><ce:label>&#x2022;</ce:label><ce:para id="para0004" view="all">PKR1-KO mice adipocytes present variation of pk2 splicing variants, PK2 and PK2L.</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0002" view="all" class="author"><ce:section-title id="cesectitle0002">Abstract</ce:section-title><ce:abstract-sec id="abss0002" view="all"><ce:simple-para id="spara008" view="all">The secreted bioactive peptide prokineticin 2 (PK2) is a potent adipokine and its central and peripheral administration reduces food intake in rodents. The <ce:italic>pk2</ce:italic> gene has two splice variants, PK2 and PK2L (PK2 long form), which is cleaved into an active peptide, PK2&#x03b2;, that preferentially binds prokineticin receptor 1 (PKR1). We investigated the role of PK2&#x03b2; in the regulation of food intake. We demonstrated that intraperitoneal injection of PK2&#x03b2;, in contrast to PK2, did not reduce food intake in mice. Exposure of hypotalamic explants to PK2, but not PK2&#x03b2;, induced phosphorylation of STAT3 and ERK. We also evidenced that in adipocytes from PKR1 knock-out mice, a model of obesity, there were higher PK2&#x03b2; levels than PK2 inducing a decreased activation of STAT3 and ERK. Our results suggest that variations in PK2 and PK2&#x03b2; levels, due to modulation of <ce:italic>pk2</ce:italic> gene splicing processes, affect food intake in mice.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0003" class="graphical" view="all"><ce:section-title id="cesectitle0003">Graphical abstract</ce:section-title><ce:abstract-sec id="abss0003" view="all"><ce:simple-para id="spara009" view="all"> [Display omitted] </ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0004">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Food intake regulation</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Adipocytes</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Prokineticin 2</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Prokineticin 2&#x03b2;</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Prokineticin receptor 1</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
